APA

Nino A., Okuda I., Wilson T. H., Yue L., Nakajima H., Tsuboi M., Carr M. C. & Seino Y. (2017). Weekly glucagon-like peptide-1 receptor agonist albiglutide as monotherapy improves glycemic parameters in Japanese patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study. : Journal of diabetes investigation.

Chicago

Nino Antonio, Okuda Inaha, Wilson Timothy H, Yue Lynn, Nakajima Hiromu, Tsuboi Maho, Carr Molly C and Seino Yutaka. 2017. Weekly glucagon-like peptide-1 receptor agonist albiglutide as monotherapy improves glycemic parameters in Japanese patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study. : Journal of diabetes investigation.

Harvard

Nino A., Okuda I., Wilson T. H., Yue L., Nakajima H., Tsuboi M., Carr M. C. and Seino Y. (2017). Weekly glucagon-like peptide-1 receptor agonist albiglutide as monotherapy improves glycemic parameters in Japanese patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study. : Journal of diabetes investigation.

MLA

Nino Antonio, Okuda Inaha, Wilson Timothy H, Yue Lynn, Nakajima Hiromu, Tsuboi Maho, Carr Molly C and Seino Yutaka. Weekly glucagon-like peptide-1 receptor agonist albiglutide as monotherapy improves glycemic parameters in Japanese patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study. : Journal of diabetes investigation. 2017.